These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22593082)

  • 1. Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1.
    Diaz J; Aranda E; Henriquez S; Quezada M; Espinoza E; Bravo ML; Oliva B; Lange S; Villalon M; Jones M; Brosens JJ; Kato S; Cuello MA; Knutson TP; Lange CA; Leyton L; Owen GI
    J Endocrinol; 2012 Aug; 214(2):165-75. PubMed ID: 22593082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
    Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
    Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75.
    Carvajal A; Espinoza N; Kato S; Pinto M; Sadarangani A; Monso C; Aranda E; Villalon M; Richer JK; Horwitz KB; Brosens JJ; Owen GI
    Breast Cancer Res Treat; 2005 Nov; 94(2):171-83. PubMed ID: 16175315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
    J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway.
    Chen HT; Tsou HK; Tsai CH; Kuo CC; Chiang YK; Chang CH; Fong YC; Tang CH
    J Cell Physiol; 2010 Jun; 223(3):737-45. PubMed ID: 20175118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.
    Kamath L; Meydani A; Foss F; Kuliopulos A
    Cancer Res; 2001 Aug; 61(15):5933-40. PubMed ID: 11479236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
    Boire A; Covic L; Agarwal A; Jacques S; Sherifi S; Kuliopulos A
    Cell; 2005 Feb; 120(3):303-13. PubMed ID: 15707890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid induces an increase of β-1,4-galactosyltransferase I expression in MDA-MB-231 breast cancer cells.
    Villegas-Comonfort S; Serna-Marquez N; Galindo-Hernandez O; Navarro-Tito N; Salazar EP
    J Cell Biochem; 2012 Nov; 113(11):3330-41. PubMed ID: 22644815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
    Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H
    Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
    Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
    Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts.
    McGowan EM; Saad S; Bendall LJ; Bradstock KF; Clarke CL
    Breast Cancer Res Treat; 2004 Feb; 83(3):211-20. PubMed ID: 14758091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM; Virnig C; Cance WG
    Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.